FibroGen Historical Income Statement
| FGEN Stock | USD 1.14 0.01 0.87% |
Historical analysis of FibroGen income statement accounts such as Selling General Administrative of 82.7 M or Total Revenue of 179.8 M can show how well FibroGen performed in making a profits. Evaluating FibroGen income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of FibroGen's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining FibroGen latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether FibroGen is a good buy for the upcoming year.
FibroGen |
About FibroGen Income Statement Analysis
FibroGen Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to FibroGen shareholders. The income statement also shows FibroGen investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
FibroGen Income Statement Chart
FibroGen Income Statement is one of the three primary financial statements used for reporting FibroGen's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of FibroGen revenue and expense. FibroGen Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, FibroGen's Interest Expense is very stable compared to the past year. As of the 22nd of April 2024, Total Revenue is likely to grow to about 179.8 M, while Depreciation And Amortization is likely to drop about 9.5 M. Add Fundamental
Total Revenue
Total revenue comprises all receipts FibroGen generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of FibroGen minus its cost of goods sold. It is profit before FibroGen operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of FibroGen. It is also known as FibroGen overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from FibroGen's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into FibroGen current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in FibroGen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.At this time, FibroGen's Interest Expense is very stable compared to the past year. As of the 22nd of April 2024, Total Revenue is likely to grow to about 179.8 M, while Depreciation And Amortization is likely to drop about 9.5 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 2.2M | 1.4M | 15.5M | 16.3M | Depreciation And Amortization | 14.8M | 18.2M | 9.9M | 9.5M |
FibroGen income statement Correlations
Click cells to compare fundamentals
FibroGen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
FibroGen income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 15.5M | 5.6M | 14.8M | 18.2M | 9.9M | 9.5M | |
| Interest Expense | 2.9M | 2.4M | 2.2M | 1.4M | 15.5M | 16.3M | |
| Selling General Administrative | 135.5M | 106.4M | 123.9M | 124.7M | 125.0M | 82.7M | |
| Total Revenue | 256.6M | 176.3M | 235.3M | 140.7M | 147.8M | 179.8M | |
| Gross Profit | 255.4M | 167.5M | 222.4M | 120.5M | 128.9M | 174.1M | |
| Other Operating Expenses | 345.9M | 368.2M | 523.8M | 441.8M | 417.0M | 323.3M | |
| Operating Income | (89.3M) | (191.9M) | (288.5M) | (301.0M) | (269.2M) | (255.7M) | |
| Ebit | (89.3M) | (191.9M) | (288.5M) | (301.0M) | (269.2M) | (255.7M) | |
| Research Development | 209.3M | 252.9M | 387.0M | 296.8M | 282.9M | 235.9M | |
| Ebitda | (73.8M) | (186.3M) | (273.7M) | (282.8M) | (259.3M) | (246.3M) | |
| Cost Of Revenue | 1.1M | 8.9M | 12.9M | 20.3M | 18.8M | 17.9M | |
| Total Operating Expenses | 344.7M | 359.3M | 511.0M | 421.5M | 398.1M | 317.6M | |
| Income Before Tax | (76.6M) | (188.9M) | (290.7M) | (294.9M) | (286.9M) | (272.5M) | |
| Total Other Income Expense Net | 12.7M | 2.9M | (2.2M) | 6.2M | (17.7M) | (16.8M) | |
| Net Income | (77.0M) | (189.3M) | (291.0M) | (295.2M) | (284.2M) | (270.0M) | |
| Income Tax Expense | 328K | 360K | 347K | 358K | 3K | 2.9K | |
| Net Income From Continuing Ops | (77.0M) | (189.3M) | (290.0M) | (293.7M) | (294.2M) | (279.5M) | |
| Net Income Applicable To Common Shares | (77.0M) | (189.3M) | (290.0M) | (293.7M) | (264.3M) | (251.1M) | |
| Tax Provision | 328K | 360K | 347K | 358K | 31K | 29.5K | |
| Interest Income | 11.6M | 15.5M | 5.6M | 7.6M | 8.9M | 9.1M | |
| Net Interest Income | 12.7M | 3.2M | (2.2M) | 6.2M | (2.7M) | (2.5M) | |
| Reconciled Depreciation | 21.5M | 22.0M | 14.8M | 10.6M | 10.7M | 14.5M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards FibroGen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, FibroGen's short interest history, or implied volatility extrapolated from FibroGen options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in FibroGen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.Note that the FibroGen information on this page should be used as a complementary analysis to other FibroGen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for FibroGen Stock analysis
When running FibroGen's price analysis, check to measure FibroGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FibroGen is operating at the current time. Most of FibroGen's value examination focuses on studying past and present price action to predict the probability of FibroGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FibroGen's price. Additionally, you may evaluate how the addition of FibroGen to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is FibroGen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FibroGen. If investors know FibroGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FibroGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.536 | Earnings Share (2.92) | Revenue Per Share 1.518 | Quarterly Revenue Growth (0.21) | Return On Assets (0.36) |
The market value of FibroGen is measured differently than its book value, which is the value of FibroGen that is recorded on the company's balance sheet. Investors also form their own opinion of FibroGen's value that differs from its market value or its book value, called intrinsic value, which is FibroGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FibroGen's market value can be influenced by many factors that don't directly affect FibroGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FibroGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if FibroGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FibroGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.